– Sathgen Therapeutics anuncia la dosificación de la primera cohorte de pacientes con MSP008-22, un nuevo medicamento contra el cáncer ~ Eficacia prometedora contra cánceres difíciles de tratar, incluido el cáncer de mama triple negativo, y mejora del efecto de la quimioterapia habitual…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.